CIK 0000812796 · Non-accelerated filer<br>Smaller reporting company
SOLIGENIX, INC.
Sign in to watch- Ticker
- SNGX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 411505029
- Phone
- 609-538-8200
- Business address
- 29 EMMONS DRIVE, SUITE B-10, PRINCETON, NJ, 08540
- Former names
- SOLIGENIX, INC., DOR BIOPHARMA INC, ENDOREX CORP, IMMUNOTHERAPEUTICS INC
- S-8 Other Securities Offered to Employees in Benefit Plans
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 10QSB Other 10QSB
- 8-K Event Item 5
- 10QSB Other 10QSB
- DEF 14A Proxy Proxy Statement
- 424B3 Offering Prospectus
- REGDEX Other REGDEX
- S-3 Offering Registration Statement
- 10KSB/A Other 10KSB/A
- 10KSB Other 10KSB
- SC 13G Stake Amended Statement of Ownership
- 8-K Event Item 5
- 8-K Event Item 5
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- SC 13D/A Stake Beneficial Ownership Report
Page 63 of 72 · 1,429 filings